Elevated levels of serum sclerostin are linked to adverse cardiovascular outcomes in peritoneal dialysis patients

ConclusionsOur data suggest that high sclerostin levels may predict the onset of CVEs and cardiovascular mortality among PD patients.
Source: International Urology and Nephrology - Category: Urology & Nephrology Source Type: research